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Abstract objective To determine the rate and predictors of early loss to follow-up (LTFU) for recently
diagnosed HIV-infected, antiretroviral therapy (ART)-ineligible adults in rural Kenya.
methods Prospective cohort study. Clients registering for HIV care between July 2008 and August
2009 were followed up for 6 months. Baseline data were used to assess predictors of pre-ART LTFU (not
returning for care within 2 months of a scheduled appointment), LTFU before the second visit and LTFU
after the second visit. Logistic regression was used to determine factors associated with LTFU before the
second visit, while Cox regression was used to assess predictors of time to LTFU and LTFU after the
second visit.
results Of 530 eligible clients, 178 (33.6%) were LTFU from pre-ART care (11.1 ⁄100 person-
months). Of these, 96 (53.9%) were LTFU before the second visit. Distance (>5 km vs. <1 km:
adjusted hazard ratio 2.6 [1.9–3.7], P < 0.01) and marital status (married vs. single: 0.5 [0.3–0.6],
P < 0.01) independently predicted pre-ART LTFU. Distance and marital status were independently
associated with LTFU before the second visit, while distance, education status and seasonality showed
weak evidence of predicting LTFU after the second visit. HIV disease severity did not predict pre-ART
LTFU.
conclusions A third of recently diagnosed HIV-infected, ART-ineligible clients were LTFU within
6 months of registration. Predictors of LTFU among ART-ineligible clients are different from those
among clients on ART. These findings warrant consideration of an enhanced pre-ART care package
aimed at improving retention and timely ART initiation.
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Introduction
During the past decade, there has been a substantial roll
out of HIV ⁄AIDS services in sub-Saharan Africa (sSA),
where an estimated 24 million people are infected
(UNAIDS 2010). A critical barrier to effective scale up of
these services is attrition of patients from care. The main
component of attrition has been identified as loss to
follow-up (LTFU) (Rosen et al. 2007).
Most studies assessing LTFU in HIV programmes have
observed patients from initiation of antiretroviral therapy
(ART) and report high rates of early attrition and mortality
(Tassie et al. 2010; Brinkhof et al. 2008; Lawn et al. 2008;
Rosen et al. 2007). A review of ART programmes in sSA
found rates of LTFU ranging from 20% at 6 months to
nearly 40% at 2 years after ART initiation (Rosen et al.
2007). The main risk factors for LTFU are lower baseline
body mass index (BMI), lower CD4 count, lower haemo-
globin, WHO stage III ⁄ IV, younger patients and being men
(Amuron et al. 2009; Bassett et al. 2009; Brinkhof et al.
2008; Toure et al. 2008; Ochieng-Ooko et al. 2010). These
data suggest that LTFU from ART programmes is mainly
associated with advanced HIV disease. Moreover, most
deaths among patients on ART occur in the early months
after treatment initiation, which has been attributed to late
access to ART and consequent severe immunosuppression
(Lawn et al. 2008; Brinkhof et al. 2008; Bassett et al. 2010;
Boulle et al. 2008; Fenner et al. 2010; Russell et al. 2010).
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Strategies to improve follow-up generally focus on
bringing lost patients back into the healthcare system
through tracing. However, for example, in Zambia’s
national treatment programme, more than two thirds of
patients who had dropped out of care could not be
contacted, even after several attempts (Krebs et al. 2008).
A systematic review of outcomes of patients lost from HIV
care and treatment programmes in resource-limited settings
found that 20–60% of patients who could be traced had
died (Brinkhof et al. 2009). As tracing patients is time-
consuming, expensive and often unsuccessful, LTFU from
HIV care remains a major challenge.
A better understanding of pre-ART LTFU is critical to
designing interventions aimed at improving long-term
care and timely initiation of ART. Few studies have
exclusively assessed pre-ART LTFU in Africa (Larson
et al. 2010; Bassett et al. 2010; Amuron et al. 2009;
Losina et al. 2010; Lessells et al. 2011). Of these, only
one study from South Africa has assessed factors associ-
ated with retention in patients who were not eligible for
ART at enrolment into HIV care (Lessells et al. 2011). It
is unclear whether their findings are generalizable to other
regions in sSA with differing HIV prevalence, services
and social context.
In this study, we aim to determine the rate of early
LTFU among adults who were recently diagnosed with
HIV but not yet eligible for ART and to identify
baseline predictors associated with pre-ART LTFU in
a rural district hospital in Kenya.
Methods
Study site
The study was conducted at the Comprehensive Care and
Research Clinic (CCRC) at Kilifi District Hospital, a
public healthcare institution located in the coastal prov-
ince of Kenya. HIV care at the CCRC is provided
according to the National AIDS and STI Control Program
guidelines, which are largely adopted from the WHO
guidelines.
Clients routinely undergo rapid voluntarily or provider-
initiated HIV testing at clinical departments or other entry
points within the hospital. HIV-infected clients are
referred to the CCRC for registration into HIV care. CD4
cell count and haemoglobin investigations are routinely
requested at registration and every 6 months thereafter or
if otherwise clinically indicated. Newly registered clients
are immediately prescribed daily cotrimoxazole prophy-
laxis, and a 2-week appointment is given to assess for side
effects, have a CD4 count done if not done at registration
and to discuss laboratory results. Clients meeting the
WHO eligibility criteria (WHO 2006) are initiated on
ART and followed up monthly thereafter. Those not
immediately eligible for ART continue to receive cotrim-
oxazole prophylaxis and are subsequently monitored at
2-month intervals.
In 2008, two additional programmes were initiated
in the clinic: a randomized controlled trial examining
the potential benefits of routine empiric de-worming of
HIV-1-infected clients who do not yet qualify for ART
[‘Anti Helminthic Trial (AHT)’, clinicaltrials.gov
NCT00507221] and a ‘Food By Prescription (FBP)’
programme, sponsored by the World Food Programme
where clients from poor socio-economic backgrounds with
susceptibility for malnutrition are enrolled and benefit
from monthly rations of cereals, flour and cooking oil.
Active tracing of defaulting clients was instituted for those
enrolled in both programmes.
Study design
A prospective, hospital cohort was designed to follow up
pre-ART adults (‡15 years old), registering for HIV care
from 1st July 2008 to 31st August 2009, and who were not
yet eligible for ART. We define pre-ART as the period from
registration to ART treatment initiation. Clients were
followed up for 6 months after their registration at the
CCRC. Exclusions included clients who were diagnosed
with HIV infection more than 3 months before registration
into care. Ineligibility for ART, an inclusion criterion for
the study, was determined by (i) CD4 count ‡200 cells ⁄ll,
(ii) WHO stage 1 or 2 in the absence of a CD4 count or (iii)
clients who did not yet have a CD4 count or WHO staging
at baseline.
Exposure variables
Upon registration at the CCRC, socio-demographic data
were collected and entered into an electronic data system.
At every follow-up visit, anthropometry and clinical data
were captured. Immunological data were captured upon
receipt of laboratory results.
Data on population density at the sub-location level
were obtained from the Kenyan national population
census. Sub-locations were categorized into densely popu-
lated and sparsely populated, using the median population
density as the cut-off threshold. Distances between sub-
locations where clients resided and the hospital, and the
shortest distance from the sub-locations to the main road
leading to the hospital were estimated using ArcInfo
(ArcCatalog version 9.2, Esri, UK) (Figure 1).
Season at registration and at dropout was determined
from the dates at registration and last clinic appointment,
Tropical Medicine and International Health volume 17 no 1 pp 82–93 january 2012
A. S. Hassan et al. Pre-ART loss to follow-up in Kenya
ª 2011 The Authors. Tropical Medicine and International Health published by John Wiley & Sons Ltd. 83
respectively. These were stratified to wet seasons (March–
June, October–November) and dry seasons (December–
February, July–September).
Outcome variables
Prior studies have used various definitions of LTFU (Fox &
Rosen 2010; Losina et al. 2010; Tassie et al. 2010;
Yiannoutsos et al. 2008; Yu et al. 2007). Data on a
multisite HIV treatment cohort in Lusaka, Zambia, were
used to determine an empirical ‘days-late’ definition of
LTFU among clients on ART. Their analyses suggest that
60 days since the last appointment was the best fitting
definition of LTFU (Chi et al. 2010).
The primary outcome of this study was pre-ART LTFU
over 6 months of follow-up after first registration into HIV
care. We defined ‘LTFU’ as clients who were more than
60 days late for a scheduled appointment and did not return
within the follow-up period. We further divided this into two
end points of interest: (i) Clients who registered for HIV care
but did not return over the given follow-up period (referred
henceforth as ‘LTFU before the second visit’), and (ii) Clients
who made at least one follow-up visit after registration but
were subsequently LTFU within the follow-up period
(referred henceforth as ‘LTFU after the second visit’).
To facilitate survival analysis, we assumed clients LTFU
before the second visit contributed 1 day of follow-up each.
All clients who were in follow-up 6 months after registra-
tion were censored at 6 months. Clients who were known to
have died or transferred care to other health facilities or
LTFU were censored at their last attended visit date.
Clients initiated on ART during the follow-up period
were censored at the date they started ART. AHT and
FBP clients were also censored at their dates of enrol-
ment into either of the two programmes, whichever came
first, as these programmes included active tracing of
defaulters.
Statistical methods
Means and standard deviations (SD) were used to present
data following a normal distribution. Median and inter-
quartile ranges were used to present data that were not
normally distributed. Cross-tabulation of baseline cate-
gorical data with AHT ⁄FBP was made to describe their
distributions. Correlation between variables was assessed
using the Pearson correlation coefficient.
Cox regression analysis was used to determine predictors
of time to LTFU and time to LTFU after the second visit.
Lexis expansion was adopted to assess the hazard of LTFU
based on changing seasons by splitting the follow-up
period into wet and dry seasons. The Kaplan–Meier
method was used to estimate the survival probability of
being LTFU from HIV care by 6 months of follow-up time.
Logistic regression analysis was used to determine factors
associated with LTFU before the second visit. A forward
stepwise model building approach was used in all the
analyses. Predictors with a likelihood ratio test P-value of
<0.10 were considered and presented in the multivariable
regression models. Analyses were carried out using Stata
statistical software (Stata Intercooled version 11; Stata-
Corp, College Station, TX, USA).
Figure 1 A map showing the location of
the Comprehensive Care and Research
Clinic (CCRC) within the Kilifi District
Hospital (KDH), and the main road linking
the hospital to other parts of the district.
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Results
Cohort characteristics
Of the 1242 clients registering for care at the CCRC
between July 2008 and August 2009, 868 were adults aged
‡15 years recently diagnosed with HIV. Of these, 530
(61.1%) were not eligible for ART at enrolment and were
included in this analysis. During the 6-month follow-up
period, 184 of these clients enrolled in the AHT [61
(11.5%)] and ⁄or FBP [75 (14.2%)], while 89 (16.8%)
started ART; 178 (33.6%) were LTFU, of whom 96
(53.9%) were LTFU before the second visit (Figure 2).
Of the 530 clients included in the analysis, 118 (22.3%)
weremen(Table 1).Atregistration, therewerenosubstantial
differences in thebaselinecharacteristicsbetweenclientswho
were later enrolled in the AHT and ⁄or FBP programmes
compared to those who were not: age (mean 32.6 vs.
32.3 years, P = 0.834), BMI (mean 20.9 vs. 21.3 kg ⁄m2,
P = 0.254), haemoglobin levels (mean 10.2 vs. 10.2 g ⁄dl,
P = 0.949) and WHO staging (WHO stage II: 40.6% vs.
47.6%, P = 0.179). However, clients who were enrolled in
*ART ineligible (530)
At least one follow up visit (434)No follow up (96)
Not on AHT**/FBP***/ART* (250)
Retained (158)
Transferred (8)
LTFU after visit 2 (82)
Died (2)
Transferred (0)
LTFU before visit 2 (96)
Died (0)
Age: 15 years or more (888)
Diagnosis: < 3 months (868)
Diagnosis: > 3 months (20)
*ART eligible (338)
Registered between
July 8 - August 9 (1242)
Age: < 15 years (354)
On AHT**/FBP***/ART* (184)
Retained (178)
Transferred (2)
LTFU after visit 2 (3) 
Died (1)
****LTFU (178)
Figure 2 Diagram showing the flow of HIV infected adults registered and followed up for routine HIV care for 6 months in a district
hospital in Kenya (N = 1242). *Antiretroviral Therapy (ART), **Anti Helminthic Trial (AHT), ***Food By prescription (FBP), ****Lost
to follow up (LTFU).
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the AHT ⁄FBP programmes had higher baseline CD4 counts
than those who were not (mean 486.8 vs. 431.4 cells ⁄ul,
P = 0.015).
The average distance from clients’ homes to the hospital
was 11.4 (SD 10.2) km and from home to the main road, 3.4
(SD 5.4) km. Direct distance to the hospital was correlated
with near distance to the main road (Pearson correlation
coefficient, 0.75) and was excluded from further analysis
based on the argument that patients living far from hospital
but near the main road had better access to the hospital than
those living far from the main road, other factors held
constant. We were unable to estimate the distance from
some clients as sub-location data were either missing 21
(4.0%) or the clients lived outside the district 49 (9.2%).
Predictors of time to LTFU
Overall, 530 newly diagnosed HIV-infected adults con-
tributed 1606 person-months of observation (pmo). Of
these, 178 (33.6% [95% CI: 29.6–37.6]) were LTFU,
giving a rate of 11.1 (9.6–12.8) ⁄100 pmo (Figure 3). In
multivariable analyses, marital status and distance
independently predicted pre-ART LTFU (Table 2).
Compared to single clients, clients who were married at
registration into HIV care had half the rate of being LTFU
(adjusted hazard ratio, aHR [95% CI], P-value; 0.5 [0.3–
0.6], P < 0.01). Clients living more than 5 km from the
main road were more likely to be LTFU than those living
within 1 km of the road (2.6 [1.9–3.7], P < 0.01).
Predictors of LTFU before the second visit
Ofthe530recentlyHIV-diagnosedadults,96(18.1%[95%CI:
14.8–21.4]) were LTFU before the second visit. In multivari-
able analysis, distance and marital status were independently
associated with LTFU before the second visit (Table 3).
Clients living more than 5 km from the main road had
the greatest odds of being LTFU before the second visit
compared to those living within a kilometre from the road
(adjusted odds ratio, aOR [95% CI], P-value; 7.0 [3.9–
12.6], P < 0.01). Being married at the time of registration
into HIV care was associated with an 80% reduction in the
odds of being LTFU before the second visit compared to
being single (0.2 [0.1–0.5], P < 0.01). Immunological
predictors were not assessed in this analysis as only two of
the 96 clients LTFU before the second visit had a CD4
count performed at registration.
Predictors of time to LTFU after the second visit
We restricted this analysis to those clients who made at
least one follow-up visit after registration into HIV care
(n = 434). Of these, 82 (18.9% [95% CI: 15.2–22.6]) were
determined LTFU after the second visit, giving a rate of 5.1
(4.1–6.4) ⁄100 pmo. Education status, distance from the
main road and time updated season showed weak evidence
of predicting LTFU after the second visit in multivariable
analysis (Table 4).
Clients with secondary ⁄higher education at registration
into HIV care had twice the rate of being LTFU after the
second visit compared to those with no formal schooling
(aHR [95% CI], P-value; 2.0 [1.1–3.6], P = 0.05). Simi-
larly, clients living more than 5 km from the main road
were more likely to be LTFU after the second visit
compared to those living within a kilometre from the road
(1.7 [1.0–3.0], P = 0.08). Clients also had a 30% lower
rate of being LTFU after the second visit in the wet seasons
compared to the dry seasons (0.7 [0.4–1.0], P = 0.09).
Discussion
Our findings from a routine HIV care clinic in a rural
district hospital in Kenya suggest that a third of recently
diagnosed HIV-infected clients registered for pre-ART care
were LTFU within 6 months of registration. More than
half of those who were LTFU did not return for follow-up
HIV care in the 6 months after registration. Distance and
marital status at registration into HIV care independently
predicted LTFU. Distance and marital status were also
independently associated with LTFU before the second
visit, while distance, level of education at registration into
HIV care and seasonality independently predicted LTFU
after the second visit.
Longer distances from health facilities reduce accessi-
bility as clients have to spend more money on travel and
take more time away from work. Although HIV services
are mostly offered free of charge, indirect costs are a
deterrent to retention of clients in care. Longer distance,
long travel time and high costs of transport are major
barriers to the access of HIV care (Amuron et al. 2009;
Ochieng-Ooko et al. 2010; Maskew et al. 2007; Losina
et al. 2010). It is possible that a small number of clients
may also have opted for HIV care in more accessible
peripheral clinics without notifying the CCRC of their
transfer.
Single clients were more likely to be LTFU from HIV
care immediately after registration. This may be because
single clients do not have a support person, hence more
likely to be negatively affected by HIV-related stigma. This
has been shown to be an important barrier to adherence
and retention in care (Merten et al. 2010; McGuire et al.
2010). Most single people are also conventionally young,
and young age has been found to be a risk factor for LTFU,
albeit in patients on ART (Karcher et al. 2007; Ochieng-
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Table 1 Distribution of baseline characteristics of newly diagnosed HIV-infected antiretroviral therapy ineligible adults registered for
routine HIV care in a district hospital in Kenya [frequency (column %), N = 530]
Risk factor Categories
On AHT ⁄ FBP
Yes (n = 128) No (n = 402) Total (n = 530)
Gender Male 17 (13.3) 101 (25.1) 118 (22.3)
Female 111 (86.7) 301 (74.9) 412 (77.7)
Age (years)* Mean (SD) 32.6 (10.8) 32.3 (10.1) 32.4 (10.2)
(Min–Max) (16.8–78.2) (15.1–75.0) (15.1–78.2)
Age group (years) 15.0–25.0 31 (24.2) 98 (24.4) 129 (24.3)
25.1–35.0 54 (42.2) 172 (42.8) 226 (42.6)
>35.0 43 (33.6) 132 (32.8) 175 (33.0)
Marital status Single 11 (8.6) 55 (13.7) 66 (12.5)
Married (monogamous ⁄
polygamous)
81 (63.3) 263 (65.4) 344 (64.9)
Separated ⁄Divorced ⁄
Widowed
36 (28.1) 84 (20.9) 120 (22.6)
Entry point In-patient wards 13 (10.2) 72 (17.9) 85 (16.1)
Out-patient ⁄VCT centers 115 (89.8) 330 (82.1) 445 (83.9)
Religion Christian 82 (64.1) 254 (63.2) 336 (63.4)
Muslim 16 (12.5) 82 (20.4) 98 (18.5)
Others 30 (23.4) 66 (16.4) 96 (18.1)
Education status No schooling 45 (35.2) 113 (28.1) 158 (29.8)
Primary schooling 69 (53.9) 207 (51.5) 276 (52.1)
Secondary ⁄Higher 14 (10.9) 82 (20.4) 96 (18.1)
Population density (sub-location
level)
Sparsely populated
(<25 people ⁄ km2)
62 (48.4) 169 (42.0) 231 (43.6)
Densely populated
(>25 people ⁄ km2)
62 (48.4) 167 (41.5) 229 (43.2)
Missing 4 (3.1) 66 (16.4) 70 (13.2)
Distance from home to the
hospital (km)*
Mean (SD) 10.2 (9.2) 11.8 (10.5) 11.4 (10.2)
(Min–Max) (0.8–37.6) (0.8–44.5) (0.8–44.5)
Group distance from home to the
hospital (km)
<5.0 49 (38.3) 138 (34.3) 187 (35.3)
5.0–20.0 50 (39.1) 136 (33.8) 186 (35.1)
>20.0 25 (19.5) 111 (27.6) 136 (25.7)
Missing 4 (3.1) 17 (4.2) 21 (4.0)
Distance from home to the
main road (km)*
Mean (SD) 3.2 (5.1) 3.4 (5.5) 3.4 (5.4)
(Min–Max) (0.0–22.3) (0.0–41.7) (0.0–41.7)
Group distance from home to
the road (km)
<1.0 66 (51.6) 194 (48.3) 260 (49.1)
1.0–5.0 31 (24.2) 87 (21.6) 118 (22.3)
>5.0 27 (21.1) 104 (25.9) 131 (24.7)
Missing 4 (3.1) 17 (4.2) 21 (4.0)
Season at registration Dry 77 (60.2) 227 (56.5) 304 (57.4)
Wet 51 (39.8) 175 (43.5) 226 (42.6)
WHO staging Stage I 76 (59.4) 182 (45.3) 258 (48.7)
Stage II 52 (40.6) 165 (41.0) 217 (40.9)
Missing 0 (0.0) 55 (13.7) 55 (10.4)
BMI (kg ⁄m2)* Mean (SD) 20.9 (3.8) 21.3 (3.7) 21.2 (3.7)
(Min–Max) (13.5–35.4) (14.5–38.7) (13.5–38.7)
BMI groups (kg ⁄m2) <18.5 37 (28.9) 62 (15.4) 99 (18.7)
‡18.5 91 (71.1) 276 (68.7) 367 (69.3)
Missing 0 (0.0) 64 (15.9) 64 (12.1)
CD4 count (cells ⁄ ul)* Mean (SD) 486.8 (184.0) 431.4 (205.8) 450.3 (200.1)
(Min–Max) (206.0–1276.0) (200.0–1100.0) (200.0–1276.0)
CD4 groups (cells ⁄ ul) 200–350.0 25 (19.5) 105 (26.1) 130 (24.5)
350.1–500.0 43 (33.6) 54 (13.4) 97 (18.3)
>500.0 49 (38.3) 66 (16.4) 115 (1.7)
Missing 11 (8.6) 177 (44.0) 188 (35.5)
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Ooko et al. 2010). However, age was not found to be an
independent predictor of pre-ART LTFU in our setting.
Interestingly, level of education at registration into HIV
care had a weak association with LTFU after the second
visit, suggesting that better-educated clients were likely to
return after registration for follow-up visits but dropout
thereafter. A plausible explanation is that educated clients
have better-paying jobs, and may opt to acquire the main
pre-ART intervention, the cheap and readily available
cotrimoxazole, over the counter to avoid the HIV-related
stigma of being seen in the clinic.
We also found weak evidence of an association between
dry seasons and LTFU after the second visit. Given that the
community is mainly agrarian, some clients may be forced
to seek alternative socio-economic activities to sustain their
livelihoods during the dry seasons. This may necessitate
working long hours or out-migration to other districts in
search of jobs.
Importantly, HIV disease severity as determined by
lower CD4 count, lower haemoglobin levels, lower BMI
and late clinical staging did not predict pre-ART LTFU in
this setting. Most previous studies on loss to HIV care in
clients on ART have identified these factors as indepen-
dently associated with LTFU. Our findings, together with
recent data from South Africa (Losina et al. 2010), suggest
that the dynamics and risk factors for pre-ART retention
differ considerably from those found among clients who
have started ART.
In view of the fact that literature suggests high rates of
early mortality after ART initiation in Africa (Lawn et al.
2008; Brinkhof et al. 2008; Bassett et al. 2010), it is
plausible that recently diagnosed HIV-infected clients
register for care and dropout while they are still healthy,
only to present later with advanced HIV disease necessi-
tating immediate ART initiation. If this is the case, then we
argue that focusing and redirecting resources towards
provision of an enhanced standard package of pre-ART
care may improve timely initiation of ART and influence
early adverse outcomes.
The pre-ART package of care may include a structured
framework of counselling and support at both testing and
registration into HIV care. This approach has been applied
in ART programmes to enhance retention and ART
adherence in different settings with relative success (Eti-
enne et al. 2010). Evidently, the same approach is equally
important in pre-ART clients registering for HIV care.
Other pre-ART care services may include provision of
prophylactic anthelmintics, isoniazid preventive therapy
(IPT), multivitamins and nutritional support in form of
food programmes. These interventions may serve as an
incentive for follow-up and counter the indirect costs
incurred.
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Figure 3 Kaplan–Meier curve showing loss to follow-up of
recently diagnosed HIV infected adults from routine pre-
antiretroviral therapy care, followed up for 6 months in a district
hospital in Kenya (N = 530).
Table 1 (Continued)
Risk factor Categories
On AHT ⁄ FBP
Yes (n = 128) No (n = 402) Total (n = 530)
Hemoglobin (g ⁄ dl)* Mean (SD) 10.2 (2.0) 10.2 (2.3) 10.2 (2.2)
(Min–Max) (5.3–15.4) (4.8–18.0) (4.8–18.0)
Hemoglobin groups (g ⁄ dl) <8.0 18 (14.1) 29 (7.2) 47 (8.9)
8.0–10.0 25 (19.5) 48 (11.9) 73 (13.8)
10.1–12.0 36 (28.1) 51 (12.7) 87 (16.4)
>12.0 18 (14.1) 26 (6.5) 44 (8.3)
Missing 31 (24.2) 248 (61.7) 279 (52.6)
AHT ⁄ FBP, Anti Helminthic Trial ⁄ Food By Prescription.
*Mean [standard deviation (SD)] and [Minimum ⁄Maximum (Min–Max)] included for continuous variables.
Site where clients have been referred from, Body Mass Index (BMI), Voluntary Counseling and Testing (VCT), World Health
Organization (WHO).
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Table 2 Cox univariable and multivariable analysis for predictors of pre-antiretroviral therapy ‘LTFU’ in newly diagnosed HIV infected
adult clients registered for routine HIV care in a district hospital in Kenya (N = 530)
Risk factors Categories
LTFU,
n ⁄ 100 pmo
n = 178
KM survival
probability
Cox univariable analysis
Cox multivariable analysis
(n = 509)
Crude
HR 95% CI P-value*
Adjusted
HR 95% CI P-value*
Gender Male 43 ⁄ 3.7 0.62 1.0 –
Female 135 ⁄ 12.4 0.65 0.9 0.6–1.3 0.52 – – –
Age group
(years)
15.0–25.0 52 ⁄ 3.6 0.59 1.0 –
25.1–35.0 73 ⁄ 6.9 0.66 0.8 0.5–1.1
>35.0 53 ⁄ 5.5 0.68 0.7 0.5–1.0 0.19 – – –
Marital status Single 34 ⁄ 1.6 0.46 1.0 – 1.0 –
Married
(monogamous ⁄
polygamous)
104 ⁄ 10.9 0.68 0.5 0.4–0.8 0.5 0.3–0.6
Separated ⁄
Divorced ⁄
Widowed
40 ⁄ 3.5 0.65 0.6 0.4–1.0 0.01 0.5 0.3–0.8 <0.01
Entry point In-patient
wards
38 ⁄ 2.2 0.54 1.0 –
Out-patient ⁄
VCT centers
140 ⁄ 13.8 0.67 0.7 0.5–0.9 0.03 – – –
Religion Christian 112 ⁄ 10.0 0.65 1.0 –
Muslim 27 ⁄ 3.4 0.71 0.8 0.5–1.2
Others 39 ⁄ 2.6 0.57 1.3 0.9–1.8 0.18 – – –
Education status No schooling 47 ⁄ 5.0 0.68 1.0 –
Primary schooling 92 ⁄ 8.4 0.66 1.1 0.8–1.6
Secondary ⁄Higher 39 ⁄ 2.7 0.57 1.4 0.9–2.2 0.28 – – –
Population
density (sub-
location level)
Sparsely populated
(<25 people ⁄ km2)
64 ⁄ 7.5 0.71 1.0 –
Densely populated
(>25 people ⁄ km2)
63 ⁄ 7.5 0.71 1.0 0.7–1.4 0.93 – – –
Distance from
home to the road
(km)
<1.0 65 ⁄ 9.1 0.74 1.0 – 1.0 –
1.0–5.0 35 ⁄ 3.6 0.69 1.3 0.8–1.9 1.3 0.9–2.0
>5.0 71 ⁄ 2.7 0.43 2.6 1.8–3.6 <0.01 2.6 1.9–3.7 <0.01
Season at
registration
Dry 108 ⁄ 9.3 0.63 1.0 –
Wet 70 ⁄ 6.8 0.68 0.9 0.6–1.2 0.39 – – –
WHO staging§ I 65 ⁄ 8.8 0.72 1.0 –
II 59 ⁄ 7.1 0.72 1.1 0.8–1.5 0.62 – – –
BMI groups
(kg ⁄m2)§
<18.5 26 ⁄ 3.0 0.70 1.0 –
‡18.5 92 ⁄ 12.7 0.73 0.9 0.6–1.4 0.77 – – –
CD4 groups
(cells ⁄ ul)§
200–350.0 14 ⁄ 5.3 0.88 1.0 –
350.1–500.0 6 ⁄ 3.9 0.94 0.6 0.2–1.5
>500.0 17 ⁄ 4.2 0.82 1.5 0.7–2.9 0.12 – – –
Hemoglobin
groups (g ⁄ dl)§
<8.0 6 ⁄ 1.8 0.86 1.0 –
8.0–10.0 6 ⁄ 2.8 0.90 0.7 0.2–2.1
10.1–12.0 12 ⁄ 3.4 0.85 1.1 04–2.9
>12.0 5 ⁄ 1.6 0.86 1.0 0.3–3.2 0.81 – – –
Time updated
season–
Dry 105 ⁄ 8.5 0.63 1.0 –
Wet 73 ⁄ 7.6 0.67 0.9 0.7–1.2 0.40 – – –
pmo, person months of observation; CI, confidence interval; KM, Kaplan–Meier.
*Likelihood Ratio Test P-value.
Kaplan–Meier Survival probabilities at 6 months of follow up.
Adjusted for other variables, Body Mass Index (BMI), Voluntary Counseling and Testing (VCT), World Health Organization (WHO).
§Missing data: WHO staging [n = 55 (10.4%)], BMI [n = 64 (12.1%)], CD4 count [n = 188 (35.5%)], Hemoglobin [n = 279 (52.6%)].
–Time varying covariate expanded to assess for the hazard of LTFU over changing seasons.
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Studies on anthelminthic drugs and IPT have shown that
these cheap and readily available interventions adminis-
tered in pre-ART clients have the potential to slow HIV
disease progression (Walson et al. 2008; Grant et al.
2005). Hence, an improved pre-ART package of care may
serve not only to enhance retention but also to slow
disease progression, treat intercurrent infections, enable
timely initiation on ART for those eligible, reduce early
mortality after starting ART and thus prolong overall
survival.
Our findings should be interpreted in the light of several
limitations. First, more than a third of the immunologi-
cal data were missing. This may have reduced the power of
our study to show an effect of CD4 count on pre-ART
LTFU. However, clinical indicators have been found to be
equally good as markers of immunosuppression and are, in
fact, the most commonly adopted method of assessing
for HIV disease severity in resource-limited settings. Our
data had almost 90% of the clinical data available, none of
which suggested an effect on LTFU.
Table 3 Logistic univariable and multivariable analyses for predictors of ‘LTFU before the second visit’ in newly diagnosed HIV infected
adult clients registered for routine HIV care in a district hospital in Kenya (N = 530)
Risk factors Categories
LTFU (%)
n = 96
\Logistic univariable analysis
Logistic multivariable analysis
(n = 509)
Crude
OR 95% CI P-value*
Adjusted
OR 95% CI P-value*
Gender Male 25 ⁄ 118 (21.2) 1.0 –
Female 71 ⁄ 412 (17.2) 0.8 0.5–1.3 0.33 – – –
Age group (years) 15.0–25.0 32 ⁄ 129 (24.6) 1.0 –
25.1–35.0 33 ⁄ 226 (14.6) 0.5 0.3–0.9
>35.0 31 ⁄ 175 (17.8) 0.7 0.4–1.1 0.06 – – –
Marital status Single 23 ⁄ 66 (34.9) 1.0 – 1.0 –
Married
(monogamous ⁄
polygamous)
51 ⁄ 344 (14.8) 0.3 0.2–0.6 0.2 0.1–0.5
Separated ⁄Divorced ⁄
Widowed
22 ⁄ 120 (18.3) 0.4 0.2–0.8 <0.01 0.3 0.1–0.6 <0.01
Entry point In-patient wards 23 ⁄ 85 (26.7) 1.0 –
Out-patient ⁄VCT
centers
73 ⁄ 445 (16.4) 0.5 0.3–0.9 0.02 – – –
Religion Christian 61 ⁄ 336 (18.2) 1.0 –
Muslim 14 ⁄ 98 (14.3) 0.8 0.4–1.4
Others 21 ⁄ 96 (21.9) 1.3 0.7–2.2 0.39 – – –
Education status No schooling 24 ⁄ 158 (15.2) 1.0 –
Primary schooling 54 ⁄ 276 (19.5) 1.4 0.8–2.3
Secondary ⁄Higher 18 ⁄ 96 (19.0) 1.3 0.7–2.5 0.51 – – –
Season at registration Dry 53 ⁄ 304 (17.5) 1.0 –
Wet 43 ⁄ 226 (19.0) 1.1 0.7–1.7 0.64 – – –
Population density
(sub-location level)
Sparsely populated
(<25 people ⁄ km2)
30 ⁄ 229 (8.6) 1.0
Densely populated
(>25 people ⁄ km2)
22 ⁄ 231 (20.0) 1.4 0.8–2.6 0.23 – – –
Distance from home to
the road (km)
<1.0 23 ⁄ 260 (8.9) 1.0 – 1.0 –
1.0–5.0 21 ⁄ 118 (17.7) 2.2 1.2–4.2 2.8 1.4–5.4
>5.0 49 ⁄ 131 (37.4) 6.2 3.5–10.7 <0.01 7.0 3.9–12.6 <0.01
WHO staging Stage I 20 ⁄ 258 (7.7) 1.0 –
Stage II 25 ⁄ 217 (11.5) 1.5 0.8–2.9 0.16 – – –
BMI groups (kg ⁄m2) <18.5 8 ⁄ 99 (8.1) 1.0 –
‡18.5 36 ⁄ 367 (9.8) 1.2 0.6–2.8 0.60 – – –
LTFU, loss to follow-up.
*Likelihood Ratio Test P-value.
Adjusted for other variables, Body Mass Index (BMI), Voluntary Counseling and Testing (VCT), World Health Organization (WHO).
Missing data: WHO staging [n = 55 (10.4%)], BMI [n = 64 (12.0%)].
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Table 4 Cox univariable and multivariable analysis for predictors of Pre-antiretroviral therapy ‘LTFU after the second visit’ in newly
diagnosed HIV infected adult clients registered for routine HIV care in a district hospital in Kenya (N = 434)
Risk factors Categories
LTFU,
n ⁄ 100 pmo
n = 82
Cox univariable analysis
Cox multivariable analysis
(n = 416)
Crude
HR 95% CI P-value*
Adjusted
HR 95% CI P-value*
Gender Male 18 ⁄ 3.7 1.0 –
Female 64 ⁄ 12.4 1.0 0.6–1.7 0.98 – – –
Age group (years) 15.0–25.0 20 ⁄ 3.6 1.0 –
25.1–35.0 40 ⁄ 6.9 1.0 0.6–1.7
>35.0 22 ⁄ 5.5 0.7 0.4–1.3 0.37 – – –
Marital status Single 11 ⁄ 1.6 1.0 –
Married
(monogamous ⁄
polygamous)
53 ⁄ 10.9 0.8 0.4–1.4
Separated ⁄
Divorced ⁄
Widowed
18 ⁄ 3.5 0.8 0.4–1.6 0.70 – – –
Entry point In-patient wards 15 ⁄ 2.2 1.0 –
Out-patient ⁄
VCT centers
67 ⁄ 13.8 0.7 0.4–1.3 0.29 – – –
Religion Christian 51 ⁄ 10.0 1.0 –
Muslim 13 ⁄ 3.4 0.8 0.4–1.5
Others 18 ⁄ 2.6 1.3 0.8–2.3 0.37 – – –
Education status No schooling 23 ⁄ 5.0 1.0 – 1.0 –
Primary schooling 38 ⁄ 8.3 1.0 0.6–1.7 1.0 0.6–1.7
Secondary ⁄Higher 21 ⁄ 2.7 1.6 0.9–3.0 0.17 2.0 1.1–3.6 0.05
Population density
(sub-location level)
Sparsely populated
(<25 people ⁄ km2)
42 ⁄ 7.5 1.0 –
Densely populated
(>25 people ⁄ km2)
33 ⁄ 7.5 0.8 0.5–1.2 0.30 – – –
Distance from home
to the road (km)
<1.0 42 ⁄ 9.1 1.0 – 1.0 –
1.0–5.0 14 ⁄ 3.6 0.9 0.5–1.6 0.9 0.5–1.7
>5.0 22 ⁄ 2.7 1.6 0.9–2.7 0.08 1.7 1.0–3.0 0.08
Season at registration Dry 55 ⁄ 9.3 1.0 –
Wet 27 ⁄ 6.8 0.7 0.4–1.1 0.08 – – –
WHO staging I 45 ⁄ 8.8 1.0 –
II 34 ⁄ 7.1 0.9 0.6–1.4 0.72 – – –
BMI groups (kg ⁄m2) <18.5 18 ⁄ 3.0 1.0 –
‡18.5 56 ⁄ 12.7 0.8 0.5–1.4 0.46 – – –
CD4 groups (cells ⁄ ul) 200–350.0 13 ⁄ 5.3 1.0 –
350.1–500.0 6 ⁄ 3.9 0.6 0.2–1.6
>500.0 16 ⁄ 4.2 1.5 0.7–3.1 0.16 – – –
Hb groups (g ⁄ dl) <8.0 6 ⁄ 1.8 1.0 –
8.0–10.0 5 ⁄ 2.8 0.6 0.2–1.8
10.1–12.0 11 ⁄ 3.4 1.0 0.4–2.7
>12.0 5 ⁄ 1.6 1.0 0.3–3.2 0.70 – – –
Time updated season§ Dry 52 ⁄ 8.5 1.0 – 1.0
Wet 30 ⁄ 7.6 0.7 0.4–1.1 0.09 0.7 0.4–1.0 0.09
pmo, person months of observation; CI, confidence interval.
*Likelihood Ratio Test P-value.
Adjusted for other variables, Loss to follow-up (LTFU), Body Mass Index (BMI), Voluntary Counseling and Testing (VCT), World Health
Organization (WHO).
Missing data: WHO staging [n = 4 (0.9%)], BMI [n = 12 (2.8%)], CD4 count [n = 94 (21.7%)], Hemoglobin [n = 185 (42.6%)].
§Time varying covariate expanded to assess for the hazard of drop out over changing season.
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Secondly, although we used an outcome definition that
was empirically defined, this definition was only previously
studied among patients on ART. Thus, applying the
definition on a pre-ART cohort may be deemed restric-
tive. The narrow time interval used may have resulted in
clients being misclassified as LTFU even when they
resumed care later, which may have resulted in an
overestimation of the LTFU rate. This limitation implies
need for a standardized approach to defining LTFU in
the pre-ART population based on empiric evidence.
Lastly, censoring clients who were later enrolled in the
AHT ⁄FBP programmes may have biased our findings. A
comparison of clients that were enrolled in the AHT ⁄FBP
programmes to those that were not suggested these groups
had similar baseline characteristics for most variables.
However, the mean baseline CD4 count of clients enrolled
in the AHT ⁄FBP programmes was higher compared to that
of those who were not enrolled. This suggests that censored
clients were in fact less immunocompromised, which may
have potentially resulted in a shift in the results with an
effect being observed on LTFU among healthier clients if
they were not enrolled in the AHT ⁄FBP programmes.
In conclusion, so far most attention has been given to
LTFU among patients on ART. Our study with recent
published data suggests that pre-ART LTFU is a wide-
spread problem in Africa. Importantly, risk factors for pre-
ART LTFU are different from those in clients on ART. Our
findings warrant consideration of an enhanced pre-ART
package aimed at improving retention, care, timely
initiation of ART and overall survival.
Further studies are needed to assess the burden and risk
factors for pre-ART LTFU in different settings. Cost
effectiveness, adherence and side effects of interventions
targeted at the pre-ART populations should be assessed to
justify their roll out.
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